Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex.

Viana GM, Gonzalez EA, Alvarez MMP, Cavalheiro RP, do Nascimento CC, Baldo G, D'Almeida V, de Lima MA, Pshezhetsky AV, Nader HB.

Int J Mol Sci. 2020 Feb 20;21(4). pii: E1459. doi: 10.3390/ijms21041459.

2.

Genome Editing for Mucopolysaccharidoses.

Poletto E, Baldo G, Gomez-Ospina N.

Int J Mol Sci. 2020 Jan 13;21(2). pii: E500. doi: 10.3390/ijms21020500. Review.

3.

Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy.

Gonzalez EA, Visioli F, Pasqualim G, de Souza CFM, Marinho DR, Giugliani R, Matte U, Baldo G.

Clin Exp Ophthalmol. 2020 Jan 10. doi: 10.1111/ceo.13713. [Epub ahead of print]

PMID:
31925897
4.

Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice.

Schuh RS, Gonzalez EA, Tavares AMV, Seolin BG, Elias LS, Vera LNP, Kubaski F, Poletto E, Giugliani R, Teixeira HF, Matte U, Baldo G.

Gene Ther. 2020 Feb;27(1-2):74-84. doi: 10.1038/s41434-019-0113-4. Epub 2019 Dec 11.

PMID:
31827259
5.

Clinical findings in Brazilian patients with adult GM1 gangliosidosis.

Giugliani L, Steiner CE, Kim CA, Lourenço CM, Santos MLSF, de Souza CFM, Brusius-Facchin AC, Baldo G, Riegel M, Giugliani R.

JIMD Rep. 2019 Jul 17;49(1):96-106. doi: 10.1002/jmd2.12067. eCollection 2019 Sep.

6.

Visual and Thermal Image Processing for Facial Specific Landmark Detection to Infer Emotions in a Child-Robot Interaction.

Goulart C, Valadão C, Delisle-Rodriguez D, Funayama D, Favarato A, Baldo G, Binotte V, Caldeira E, Bastos-Filho T.

Sensors (Basel). 2019 Jun 26;19(13). pii: E2844. doi: 10.3390/s19132844.

7.

Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases.

Poletto E, Pasqualim G, Giugliani R, Matte U, Baldo G.

Genet Mol Biol. 2019;42(1 suppl 1):261-285. doi: 10.1590/1678-4685-GMB-2018-0100. Epub 2019 May 23.

8.

Lysosomal diseases: Overview on current diagnosis and treatment.

Poswar FO, Vairo F, Burin M, Michelin-Tirelli K, Brusius-Facchin AC, Kubaski F, Souza CFM, Baldo G, Giugliani R.

Genet Mol Biol. 2019;42(1 suppl 1):165-177. doi: 10.1590/1678-4685-GMB-2018-0159. Epub 2019 Apr 25.

9.

Spinal cord compression by a pulmonary hernia.

Baldo GV, Casagrande A, Barbosa DRF, Souza Junior W, Souza MP, Maito Z.

Rev Bras Ortop. 2018 Sep 20;53(6):802-804. doi: 10.1016/j.rboe.2018.09.002. eCollection 2018 Nov-Dec.

11.

Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene Therapy.

Schuh RS, Bidone J, Poletto E, Pinheiro CV, Pasqualim G, de Carvalho TG, Farinon M, da Silva Diel D, Xavier RM, Baldo G, Matte U, Teixeira HF.

Pharm Res. 2018 Sep 26;35(11):221. doi: 10.1007/s11095-018-2503-5.

PMID:
30259180
12.

In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system.

Schuh RS, Poletto É, Pasqualim G, Tavares AMV, Meyer FS, Gonzalez EA, Giugliani R, Matte U, Teixeira HF, Baldo G.

J Control Release. 2018 Oct 28;288:23-33. doi: 10.1016/j.jconrel.2018.08.031. Epub 2018 Aug 28.

PMID:
30170069
13.

Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS.

Giugliani R, Vairo F, Kubaski F, Poswar F, Riegel M, Baldo G, Saute JA.

Lancet Child Adolesc Health. 2018 Jan;2(1):56-68. doi: 10.1016/S2352-4642(17)30087-1. Epub 2017 Oct 24. Review. Erratum in: Lancet Child Adolesc Health. 2018 Jan;2(1):e1.

PMID:
30169196
14.

Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy.

Poswar FO, de Souza CFM, Giugliani R, Baldo G.

Heart Vessels. 2019 Feb;34(2):290-295. doi: 10.1007/s00380-018-1242-1. Epub 2018 Aug 22.

PMID:
30136169
15.

CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts.

de Carvalho TG, Schuh R, Pasqualim G, Pellenz FM, Filippi-Chiela EC, Giugliani R, Baldo G, Matte U.

Gene. 2018 Dec 15;678:33-37. doi: 10.1016/j.gene.2018.08.004. Epub 2018 Aug 3.

PMID:
30081189
16.

Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology.

Schuh RS, Poletto É, Fachel FNS, Matte U, Baldo G, Teixeira HF.

J Colloid Interface Sci. 2018 Nov 15;530:243-255. doi: 10.1016/j.jcis.2018.06.058. Epub 2018 Jun 22.

PMID:
29982016
17.

Intra-articular nonviral gene therapy in mucopolysaccharidosis I mice.

Bidone J, Schuh RS, Farinon M, Poletto É, Pasqualim G, de Oliveira PG, Fraga M, Xavier RM, Baldo G, Teixeira HF, Matte U.

Int J Pharm. 2018 Sep 5;548(1):151-158. doi: 10.1016/j.ijpharm.2018.06.049. Epub 2018 Jun 27.

PMID:
29940298
18.

Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice.

Gonzalez EA, Martins GR, Tavares AMV, Viegas M, Poletto E, Giugliani R, Matte U, Baldo G.

Life Sci. 2018 Mar 1;196:102-109. doi: 10.1016/j.lfs.2018.01.020. Epub 2018 Jan 31.

PMID:
29366749
19.

A simple protocol for transfecting human mesenchymal stem cells.

de Carvalho TG, Pellenz FM, Laureano A, da Rocha Silla LM, Giugliani R, Baldo G, Matte U.

Biotechnol Lett. 2018 Mar;40(3):617-622. doi: 10.1007/s10529-018-2505-8. Epub 2018 Jan 17.

PMID:
29344849
20.

Neonatal hyperglycemia induces cell death in the rat brain.

Rosa AP, Mescka CP, Catarino FM, de Castro AL, Teixeira RB, Campos C, Baldo G, Graf DD, de Mattos-Dutra A, Dutra-Filho CS, da Rosa Araujo AS.

Metab Brain Dis. 2018 Feb;33(1):333-342. doi: 10.1007/s11011-017-0170-6. Epub 2017 Dec 19.

PMID:
29260360

Supplemental Content

Loading ...
Support Center